SODIUM IODIDE I 123 (MALLINCKRODT NUCLEAR MEDICINE LLC)
Welcome to the PulseAid listing for the SODIUM IODIDE I 123 drug offered from MALLINCKRODT NUCLEAR MEDICINE LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | MALLINCKRODT NUCLEAR MEDICINE LLC |
| NON-PROPRIETARY NAME: | sodium iodide i 123 |
| SUBSTANCE NAME: | SODIUM IODIDE I-123 |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-11-04 |
| END MARKETING DATE: | 0000-00-00 |
SODIUM IODIDE I 123 HUMAN PRESCRIPTION DRUG Details:
| Item Description | SODIUM IODIDE I 123 from MALLINCKRODT NUCLEAR MEDICINE LLC |
| LABELER NAME: | MALLINCKRODT NUCLEAR MEDICINE LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(uCi/1) |
| START MARKETING DATE: | 2015-11-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69945-601_6b26fa17-b31e-418f-8d61-44ba97cc513b |
| PRODUCT NDC: | 69945-601 |
| APPLICATION NUMBER: | ANDA071909 |
Other SODIUM IODIDE I-123 Pharmaceutical Manufacturers / Labelers:
